Robert R. Quinn

TL;DR: This work argues that analyses comparing the outcomes of renal replacement therapy (RRT) modalities should include patients eligible for the therapies being compared and that the way that patients are assigned to treatment groups should reflect decision-making in clinical practice, and explores several key methodological challenges in the design of observational research in ESRD.

TL;DR: It is suggested that eGFR and albuminuria should be used together to determine the risk of cardiovascular outcomes in transplant recipients.

TL;DR: The relationship between kidney failure and age varies with age, and an age-dependent effect, rather than a constant effect, needs to be specified to accurately predict risk.

TL;DR: It is shown that transplantation is cost-effective for all age groups and a strategy of restricting access to transplantation to younger patients does not result in large cost savings and provides only small improvements in expected life-years at the expense of significantly worse outcomes in older patients.

TL;DR: Clarithromycin and erythromycin were frequently co-prescribed in kidney transplant recipients on CNIs despite known drug interactions, and use was associated with a higher risk of hospitalization compared with azithromyzin users.